A Phase IV, 6-Week, Randomised, Double-Blind, Multicentre, Parallel Group, Comparative Study to Evaluate the Efficacy of Rosuvastatin 5mg and Atorvastatin 10mg in UK [United Kingdom] Asian Subjects With Primary Hypercholesterolaemia.

Trial Profile

A Phase IV, 6-Week, Randomised, Double-Blind, Multicentre, Parallel Group, Comparative Study to Evaluate the Efficacy of Rosuvastatin 5mg and Atorvastatin 10mg in UK [United Kingdom] Asian Subjects With Primary Hypercholesterolaemia.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Atorvastatin; Rosuvastatin
  • Indications Hypercholesterolaemia; Lipid metabolism disorders
  • Focus Therapeutic Use
  • Acronyms SHUKRA
  • Sponsors AstraZeneca
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Mar 2010 Actual patient number (55) added as reported by ClinicalTrials.gov.
    • 01 Aug 2008 Status changed from in progress to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top